Lorazepam vs diazepam for pediatric status epilepticus: A randomized clinical trial

JAMA

Volumn 311, Issue 16, 2014, Pages 1652-1660

  Chamberlain, James M ^a,b   Okada, Pamela ^c   Holsti, Maija ^b,d   Mahajan, Prashant ^b,e   Brown, Kathleen M ^a,b   Vance, Cheryl ^b,f   Gonzalez, Victor ^b,g   Lichenstein, Richard ^h   Stanley, Rachel ^b,i   Brousseau, David C ^b,j   Grubenhoff, Joseph ^b,k   Zemek, Roger ^l   Johnson, David W ^m   Clemons, Traci E ⁿ   Baren, Jill ^b,o  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b Pediatric Emergency Care Applied Research Network   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j MEDICAL COLLEGE OF WISCONSIN   (United States)

^k CHILDREN S HOSPITAL   (United States)

^l CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^m ALBERTA CHILDREN'S HOSPITAL   (Canada)

ⁿ EMMES CORPORATION   (United States)

^o CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; FOSPHENYTOIN SODIUM; LORAZEPAM;

ADOLESCENT; ADULT; ARTICLE; ASSISTED VENTILATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EPILEPTIC STATE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REPEATED DRUG DOSE; SEDATION; UNITED STATES;

ANTICONVULSANTS; CHILD, PRESCHOOL; DIAZEPAM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; LORAZEPAM; MALE; RECURRENCE; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84898832834     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.2625     Document Type: Article

References (28)

1. US Department of Health and Human Services. 2010 national statistics. http://hcupnet.ahrq.gov/HCUPnet.jsp. Accessed July 5, 2013.
2. Shinnar S, Berg AT, Moshe SL, et al. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics. 1996;98(2, pt 1):216-225. (Pubitemid 26262133)
3. De Negri M, Baglietto MG. Treatment of status epilepticus in children. Paediatr Drugs. 2001;3(6):411-420. (Pubitemid 32588996)
4. Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology. 1990;40(5)(suppl 2):32-42.
5. Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Epilepsia. 1996;37(suppl 1):S74-S80. (Pubitemid 26181160)
6. Appleton R, Choonara I, Martland T, Phillips B, Scott R, Whitehouse W. The treatment of convulsive status epilepticus in children: The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party. Arch Dis Child. 2000;83(5):415-419.
7. Manno EM. New management strategies in the treatment of status epilepticus. Mayo Clin Proc. 2003;78(4):508-518. (Pubitemid 36373953)
8. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999;40(suppl 1):S59-S63, discussion S64-S66.
9. Sabo-Graham T, Seay AR. Management of status epilepticus in children. Pediatr Rev. 1998;19(9):306-309, quiz 310.
10. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249(11):1452-1454. (Pubitemid 13158575)
11. Cock HR, Schapira AHV. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM. 2002;95(4):225-231.
12. Chiulli DA, Terndrup TE, Kanter RK. The influence of diazepam or lorazepam on the frequency of endotracheal intubation in childhood status epilepticus. J Emerg Med. 1991;9(1-2):13-17.
13. Giang DW, McBride MC. Lorazepam versus diazepam for the treatment of status epilepticus. Pediatr Neurol. 1988;4(6):358-361.
14. Chin RF, Neville BG, Peckham C, Wade A, Bedford H, Scott RC. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study [published correction appears in Lancet Neurol. 2008;7(9):771]. Lancet Neurol. 2008;7(8):696-703.
15. Qureshi A, Wassmer E, Davies P, Berry K, Whitehouse WP. Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children. Seizure. 2002;11(3):141-144. (Pubitemid 34693042)
16. Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol. 1995;37(8):682-688.
17. Martland T, Baxter P, Rittey C. Is there an agreed treatment for children in status epilepticus? Dev Med Child Neurol. 1998;40(4):286-287. (Pubitemid 28171810)
18. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(suppl 1):S3-S8, discussion S21-S22.
19. Appleton R, Choonara I, Martland T, Phillips B, Scott R, Whitehouse W. The treatment of convulsive status epilepticus in children: The Status Epilepticus Working Party. Arch Dis Child. 2000;83(5):415-419.
20. Food and Drug Administration. Guidance for institutional review boards, clinical investigators, and sponsors: Exception from Informed Consent Requirements for Emergency Research. March 2011. http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/UCM249673.pdf. Accessed April 13, 2012.
21. Chamberlain JM, Capparelli EV, Brown KM, et al Pediatric Emergency Care Applied Research Network (PECARN). Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus. J Pediatr. 2012;160(4):667-672, e2.
22. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27(7):1325-1329. (Pubitemid 29379371)
23. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631-637.
24. Chen YHJ, DeMets DL, Lan KKG. Increasing the sample size when the unblinded interim result is promising. Stat Med. 2004;23(7):1023-1038. (Pubitemid 38477065)
25. Silbergleit R, Durkalski V, Lowenstein D, et al NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591-600.
26. Treiman DM, Meyers PD, Walton NY, et al Veterans Affairs Status Epilepticus Cooperative Study Group. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med. 1998;339(12):792-798. (Pubitemid 28447452)
27. Woods D, Thomas E, Holl J, Altman S, Brennan T. Adverse events and preventable adverse events in children. Pediatrics. 2005;115(1):155-160. (Pubitemid 43046294)
28. Krug SE, Frush K; Committee on Pediatric Emergency Medicine, American Academy of Pediatrics. Patient safety in the pediatric emergency care setting. Pediatrics. 2007;120(6):1367-1375. (Pubitemid 350223690)